Protéines recombinantes
Protéines modifiées ou manipulées codées par l'ADN recombinant et adaptées à divers usages, notamment la modification de séquences génétiques, la production massive de protéines et la fabrication de produits commerciaux.
À utiliser avec (application)
- (2)
- (2,347)
- (79)
- (3)
- (1)
- (1)
- (2)
- (354)
- (6,089)
- (7)
- (2)
- (7)
- (2)
- (1)
- (1)
- (2)
- (6)
- (43)
- (2)
- (2)
- (2)
- (2)
- (1)
- (2)
- (3)
- (1)
- (157)
- (1)
- (3)
- (1)
- (5)
- (10)
- (26,065)
- (1)
- (2)
- (1)
- (21)
- (1)
- (12,629)
- (1,160)
- (2)
- (2)
- (8)
- (1)
- (110)
- (8)
- (2)
- (1)
- (8)
- (1)
- (1)
- (1)
- (41)
- (255)
- (159)
- (1)
- (7)
- (1)
- (1)
- (3)
- (4)
- (1)
- (11,338)
- (25)
- (3)
- (30)
- (14)
- (10)
- (72)
- (13)
- (76)
- (78)
- (34)
- (1)
- (13)
- (1)
- (1,155)
- (1)
- (157)
- (26)
- (8)
- (1)
- (2)
- (2)
- (1)
- (18)
- (2)
- (21,641)
- (2,889)
- (4)
- (1)
- (2,842)
- (4)
- (6)
- (1)
- (1)
- (3)
- (1)
- (1)
- (1)
- (11,317)
- (3)
- (6)
- (1)
- (1)
- (6)
- (7)
- (5)
- (1)
- (6)
- (1)
- (5,573)
- (6)
- (4)
- (3)
- (12)
- (2)
- (4)
- (5)
- (4)
- (5)
- (1)
- (13,019)
- (1,863)
- (1)
- (1)
Conjugué
- (11)
- (1)
- (4)
- (2)
- (9)
- (8)
- (1)
- (24)
- (1)
- (3)
- (1)
- (1)
- (3)
- (2)
- (1)
- (9)
- (2)
- (1)
- (13)
- (5)
- (1)
- (2)
- (3)
- (35,857)
Recombinant
- (70)
- (34,771)
Forme
- (1)
- (23,075)
- (9,221)
- (29)
- (146)
- (26)
- (35)
Statut réglementaire
- (75)
- (30,552)
Résultats de la recherche filtrée
Les produits de certains de nos fournisseurs ne s'affichent pas dans les résultats de la recherche filtrée. Veuillez
supprimer tous les filtres
pour voir ces produits.
Rechercher dans les résultats
Recherche par mot-clé:
Effacer la recherche
1
–
15
de
40,125
résultats
| Poids moléculaire (g/mol) | 17.4 kDa |
|---|---|
| Numéro d'enregistrement | P01375 |
| Séquence | VRSSSRTPSD KPVAHVVANP QAEGQLQWLN RRANALLANG VELRDNQLVV PSEGLYLIYS QVLFKGQGCP STHVLLTHTI SRIAVSYQTK VNLLSAIKSP CQRETPEGAE AKPWYEPIYL GGVFQLEKGD RLSAEINRPD YLDFAESGQV YFGIIAL |
| Concentration en endotoxines | <1 EU/μg |
| Activité biologique | The ED50 as determined by the cytolysis of murine L929 cells in the presence of Actinomycin D is ≤ 0.05 ng/ml, corresponding to a specific activity of ≥ 2 x 10^7 units/mg |
| Conjugué | Unconjugated |
| Sources | E. coli |
| Nom | Human TNF-alpha |
| Forme | Lyophilized |
| Contenu et stockage | -20°C |
| Symbole de gène | Tnf |
| Nom usuel | TNF alpha |
| À utiliser avec (application) | Control,Western Blot Control,ELISA Standard,Bioactivity |
| Alias du gène | APC1 protein; Cachectin; C-domain 1; C-domain 2; cTNF; DADB-70P7.1; DIF; ICD1; ICD2; Intracellular domain 1; Intracellular domain 2; N-terminal fragment; NTF; RATTNF; Tnf; TNF alpha; TNF superfamily; TNF α; TNF, macrophage-derived; TNF, monocyte-derived; TNFA; TNF-a; TNFalpha; TNF-alpha; Tnfsf1a; TNFSF2; TNFα; TNLG1F; Tumor necrosis factor; tumor necrosis factor (TNF superfamily, member 2); tumor necrosis factor alpha; tumor necrosis factor alpha (cachetin); tumor necrosis factor alpha precursor; tumor necrosis factor ligand 1F; tumor necrosis factor ligand superfamily member 2; Tumor necrosis factor, membrane form; Tumor necrosis factor, soluble form; tumor necrosis factor-alpha; tumor necrosis factor-alpha precursor; tumor-necrosis factor; tumour necrosis factor |
| Grade de qualité ou de pureté | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Système d’expression | E. coli |
| ID du gène (Entrez) | 7124 |
| Formule | Protein with no preservative |
| Recombinant | Recombinant |
Invitrogen™ eBioscience™ Concanavalin A (Con A) Solution (500X)
The Concanavalin A (Con A) Solution (500X) is a ready-to-use solution of Con A in aqueous buffer.
| Format | Vial |
|---|---|
| Sous-type de protéine | Lectins |
| Sources | Canavlia Ensiformis |
| Gamme de produit | eBioscience |
| Forme | Solution |
Invitrogen™ Vaccinia Virus B18R (Carrier-Free) Recombinant Protein, eBioscience™
Recombinant Protein
| Plage de pH | 7.5 |
|---|---|
| Poids moléculaire (g/mol) | 48 kDa |
| Séquence | Vaccinia Virus B18R, ammino acids His20-Glu351 (Accession # D01019) with a His-tag |
| Type de produit | Protein |
| Concentration en endotoxines | <0.01 ng/μg |
| Activité biologique | Pre-incubation of recombinant IFN-alpha 2 A with 0.1 μg/mL B18R for 1 hour (at RT was found to completely neutralize the activity of 1 ng/mL IFN-alpha 2 a.) |
| Sous-type de protéine | Recombinant |
| Conjugué | Unconjugated |
| Espèces | Bovine,Human,Mouse,Pig,Rabbit,Rat |
| Concentration | 0.5 mg/mL |
| Sources | Vaccinia Virus |
| Nom | Vaccinia Virus B18R (Carrier-Free) |
| Forme | Liquid |
| Contenu et stockage | -80°C |
| Symbole de gène | Vaccinia Virus-Encoded Neutralizing Type I Interferon Receptor; Type I IFN inhibitor |
| Nom usuel | Vaccinia Virus B18R |
| À utiliser avec (application) | Bioactivity,Functional Assay |
| Grade de qualité ou de pureté | >98% by SDS-PAGE |
| Système d’expression | Insect cells |
| Méthode de purification | Purified |
| Étiquette de la protéine | His-tag |
| Durée de conservation | 12 Months |
| Formule | PBS with no preservative; pH 7.5 |
| Recombinant | Recombinant |
| Poids moléculaire (g/mol) | 26.9 kDa |
|---|---|
| Numéro d'enregistrement | Q9BXY4 |
| Séquence | MHPNVSQGCQ GGCATCSDYN GCLSCKPRLF FALERIGMKQ IGVCLSSCPS GYYGTRYPDI NKCTKCKADC DTCFNKNFCT KCKSGFYLHL GKCLDNCPEG LEANNHTMEC VSIVHCEVSE WNPWSPCTKK GKTCGFKRGT ETRVREIIQH PSAKGNLCPP TNETRKCTVQ RKKCQKGERG KKGRERKRKK PNKGESKEAI PDSKSLESSK EIPEQRENKQ QQKKRKVQDK QKSVSVSTVH |
| Concentration en endotoxines | <1 EU/μg |
| Activité biologique | R-Spondin-3 enhances BMP-2-mediated differentiation of MC3T3-E1 cells. The expected ED50 for this effect is 0.8 -2.0 ug/ml |
| Conjugué | Unconjugated |
| Sources | CHO cells |
| Nom | Human R-Spondin-3 |
| Forme | Lyophilized |
| Contenu et stockage | -20°C |
| Symbole de gène | RSPO3 |
| Nom usuel | RSPO3 |
| À utiliser avec (application) | Control,Bioactivity |
| Alias du gène | 2810459H04Rik; AW742308; Cabriolet; cristin 1; Cristin1; cristin-1; cysteine-rich and single thrombospondin domain-containing protein 1; hPWTSR; hRspo3; Nucleopondin; protein with TSP type-1 repeat; PWTSR; RGD1563246; Roof plate-specific spondin-3; Rspo3; R-spondin 3; R-spondin 3 homolog; R-spondin 3 homolog (Xenopus laevis); R-spondin 3-like protein; R-spondin-3; Thrombospondin type-1 domain-containing protein 2; thrombospondin, type I, domain 2; thrombospondin, type I, domain containing 2; Thsd2; Unknown (protein for MGC:137973) |
| Grade de qualité ou de pureté | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
| Système d’expression | CHO cells |
| ID du gène (Entrez) | 84870 |
| Formule | Protein with no preservative |
| Recombinant | Recombinant |
| Poids moléculaire (g/mol) | 8 kDa |
|---|---|
| Numéro d'enregistrement | P48061 |
| Séquence | KPVSLSYRCP CRFFESHVAR ANVKHLKILN TPNCALQIVA RLKNNNRQVC IDPKLKWIQE YLEKALNK |
| Concentration en endotoxines | <1 EU/μg |
| Activité biologique | Determined by its ability to chemoattract IL-2-activated human T cells using a concentration range of 20.0-80.0 ng/ml |
| Conjugué | Unconjugated |
| Sources | E. coli |
| Nom | Human CXCL12 (SDF-1a) |
| Forme | Lyophilized |
| Contenu et stockage | -20°C |
| Symbole de gène | CXCL12 |
| Nom usuel | CXCL12 alpha |
| À utiliser avec (application) | Control,Western Blot Control,ELISA Standard,Bioactivity |
| Alias du gène | 12-O-tetradecanoylphorbol 13-acetate repressed protein 1; C Cmotif chemokine; C X C motif chemokine; CC motif chemokine; CCmotif chemokine; chemokine (C-X-C motif) ligand 12; chemokine (C-X-C motif) ligand 12 (stromal cell-derived factor 1); CXC; CXC motif chemokine; C-X-C motif chemokine 12; C-X-C motif chemokine ligand 12; CXCL; Cxcl12; H-SDF-1-alpha; Intercrine reduced in hepatomas; IRH; Pbsf; pre-B cell growth-stimulating factor; pre-B-cell growth-stimulating factor; SCYB12; SDF 1 a; SDF 1 alpha; SDF 1α; SDF1; SDF-1; SDF1 alpha; SDF-1 gamma; SDF1A; SDF-1-alpha(3-67); SDF1B; SDF-1-beta(3-72); SDF1α; Stromal cell-derived factor 1; stromal cell-derived factor-1 alpha; stromal cell-derived factor-1 gamma; thymic lymphoma cell-stimulating factor; TLSF; Tpar1 |
| Grade de qualité ou de pureté | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
| Système d’expression | E. coli |
| ID du gène (Entrez) | 6387 |
| Formule | Protein with no preservative |
| Recombinant | Recombinant |
| Poids moléculaire (g/mol) | 39.8 kDa |
|---|---|
| Numéro d'enregistrement | Q7Z6A9 |
| Séquence | KESCDVQLYI KRQSEHSILA GDPFELECPV KYCANRPHVT WCKLNGTTCV KLEDRQTSWK EEKNISFFIL HFEPVLPNDN GSYRCSANFQ SNLIESHSTT LYVTDVKSAS ERPSKDEMAS GGPKSCDKTH TCPPCPAPEL LGGPSVFLFP PKPKDTLMIS RTPEVTCVVV DVSHEDPEVK FNWYVDGVEV HNAKTKPREE QYNSTYRVVS VLTVLHQDWL NGKEYKCKVS NKALPAPIEK TISKAKGQPR EPQVYTLPPS RDELTKNQVS LTCLVKGFYP SDIAVEWESN GQPENNYKTT PPVLDSDGSF FLYSKLTVDK SRWQQGNVFS CSVMHEALHN HYTQKSLSLS PGK |
| Concentration en endotoxines | <1 EU/μg |
| Activité biologique | Determined by its ability to bind recombinant Murine HVEM Fc in a functional ELISA. |
| Conjugué | Unconjugated |
| Sources | CHO cells |
| Nom | Human BTLA Fc |
| Forme | Lyophilized |
| Contenu et stockage | -20°C |
| Symbole de gène | BTLA |
| Nom usuel | BTLA (CD272) |
| À utiliser avec (application) | Control,ELISA Standard,Binding Assay |
| Alias du gène | A630002H24; B and T lymphocyte associated; B and T lymphocyte associated protein; B and T lymphocyte attenuator; B- and T-lymphocyte attenuator; B- and T-lymphocyte-associated protein; BTLA; BTLA_HUMAN; BTLA1; CD272; CD272 antigen; FLJ16065; MGC129743 |
| Grade de qualité ou de pureté | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
| Système d’expression | CHO cells |
| ID du gène (Entrez) | 151888 |
| Étiquette de la protéine | Fc-tag |
| Formule | Protein with no preservative |
| Recombinant | Recombinant |
